Experimental mRNA melanoma vaccine shows promise in landmark trial

A breakthrough in skin cancer treatment could soon change how doctors prevent melanoma from returning. In a landmark clinical trial, a personalized mRNA cancer vaccine combined with standard immunotherapy significantly lowered the risk of recurrence and disease spread in high-risk patients following surgery. Dr. Tyler Kang, an oncologist with North Bay Health, joined us on Mornings on 2 to discuss what this milestone means for the future of personalized cancer care.